Endo has announced the decision to cease the production and sale of Endo Aesthetics' Qwo® (collagenase clostridium histolyticum-aaes). After careful consideration, we have determined that QWO does not represent a viable commercial opportunity for Endo. Read the press release here.
QWO remains an FDA-approved product, so practices may continue to use unexpired QWO that they have in stock, as well as order additional supply through February 28, 2023. All new orders are not eligible for return pursuant to the program referenced below. To order more QWO, please contact McKesson directly at 888-587-8796.
From January 1 to March 31, 2023, Endo is offering the QWO Return Goods Program.
Customers can receive a refund in the form of their original payment method or a credit to their McKesson account by returning unused, unopened QWO that was purchased through McKesson prior to December 7, 2022. The returned product must be physically received by McKesson by March 31, 2023, or no refund or credit will be given. Please note that samples are not eligible for returns.
Please see the second page of the return form to understand what product is eligible for return, as well as other terms and conditions of the QWO Return Goods Program.
We are offering the new order window and the ability to return QWO in an effort to transition the product out of the market in a way that is respectful to practitioners and patients.
For medical inquiries, please contact Endo Medical Information at 1-800-462-ENDO (3636) from 9 a.m. to 8 p.m. ET Monday through Thursday or from 9 a.m. to 6 p.m. ET on Friday.